-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, G0JsuKcrexu7hpRS7TGxCnrrXzgjGU8ykG814PgYszmty0roDvgkDTuGbDbIiROj ZdcQhC2qrM+ko+U+hB8zpg== 0000950144-03-008112.txt : 20030627 0000950144-03-008112.hdr.sgml : 20030627 20030627140146 ACCESSION NUMBER: 0000950144-03-008112 CONFORMED SUBMISSION TYPE: S-8 POS PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20030627 EFFECTIVENESS DATE: 20030627 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NABI BIOPHARMACEUTICALS CENTRAL INDEX KEY: 0000072444 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 591212264 STATE OF INCORPORATION: DE FISCAL YEAR END: 1225 FILING VALUES: FORM TYPE: S-8 POS SEC ACT: 1933 Act SEC FILE NUMBER: 333-38866 FILM NUMBER: 03760566 BUSINESS ADDRESS: STREET 1: 5800 PARK OF COMMERCE BLVD N W STREET 2: STE 322 CITY: BOCA RATON STATE: FL ZIP: 33487 BUSINESS PHONE: 5619895800 MAIL ADDRESS: STREET 1: 5800 PARK OF COMMERCE BLVD NW STREET 2: STE 322 CITY: BOCA RATON STATE: FL ZIP: 33487 FORMER COMPANY: FORMER CONFORMED NAME: NABI /DE/ DATE OF NAME CHANGE: 19960405 FORMER COMPANY: FORMER CONFORMED NAME: NORTH AMERICAN BIOLOGICALS INC DATE OF NAME CHANGE: 19920703 S-8 POS 1 g83598sv8pos.htm NABI BIOPHARMACEUTICALS S-8 POS 333-38866 NABI BIOPHARMACEUTICALS S-8 POS 333-38866
Table of Contents

Registration No. 333-38866

As filed with the Securities and Exchange Commission on June 27, 2003.

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

POST-EFFECTIVE AMENDMENT NO. 1
TO

FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933

Nabi Biopharmaceuticals

(Exact Name of Registrant as Specified in its Charter)
     
Delaware   59-1212264
 
(State or Other Jurisdiction of
Incorporation or Organization)		   (I.R.S. Employer Identification No.)
     
5800 Park of Commerce Boulevard, N.W.
Boca Raton, FL		   33487
 
(Address of Principal Executive Offices)   (Zip Code)

Nabi-Rockville Savings & Retirement Plan

(Full Title of the Plan)

     
Thomas H. McLain
Nabi Biopharmaceuticals
5800 Park of Commerce Boulevard, N.W.
Boca Raton, FL 33487
(561) 989-5800		   Copy to: Constantine Alexander, Esq.
Nutter McClennen & Fish LLP
155 Seaport Boulevard
Boston, MA 02210-2604
(617) 439-2000
(Name, Address, and Telephone Number, Including Area Code, of Agent for Service)

 

DEREGISTRATION OF SECURITIES
SIGNATURES

Table of Contents

DEREGISTRATION OF SECURITIES

     On June 8, 2000, Nabi Biopharmaceuticals, a Delaware corporation (the “Registrant”), filed with the Securities and Exchange Commission (the “Commission”) a registration statement on Form S-8 (Registration No. 333-38866) (the “Registration Statement”) covering 100,000 shares of Common Stock, $.10 par value per share (the “Common Stock”), to be purchased pursuant to the Nabi-Rockville Savings & Retirement Plan (the “Plan”). Pursuant to Rule 416(b) under the Securities Act of 1933, as amended (the “Securities Act”), the Registration Statement also covered an indeterminate number of additional shares of Common Stock to be issued under the Plan as a result of a stock dividend, stock split, or other recapitalization. Pursuant to Rule 416(c) under the Securities Act, the Registration Statement also covered an indeterminate amount of interests to be offered or sold pursuant to the Plan.

     On January 1, 2002, the Plan was merged into the Nabi Savings & Retirement Plan. Effective as of the merger date, the offering under the Plan was terminated. The Registrant is filing this Post-Effective Amendment No. 1 to the Registration Statement (the “Amendment”) to deregister 100,000 shares of Common Stock, an indeterminate number of additional shares of Common Stock, and an indeterminate amount of interests remaining unsold at the termination of the offering.

     The Plan will file with the Commission a Form 15 to suspend the duty under Section 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), to file reports required by Section 13(a) of the Exchange Act with respect to the Plan interests. A duty to file reports under Section 13(a) or 15(d) will remain for the Common Stock and certain other classes of securities.

 

Table of Contents

SIGNATURES

     The Registrant. Pursuant to the requirements of the Securities Act, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Amendment to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Boca Raton, State of Florida, on this 27th day of June, 2003.

         
    NABI BIOPHARMACEUTICALS
         
    By:   /s/ Thomas H. McLain
       
        Thomas H. McLain
President and Chief Executive Officer

     Pursuant to the requirements of the Securities Act, this Amendment has been signed by the following persons in the capacities and on the dates indicated.

         
Signature   Title   Date
 
/s/ Thomas H. McLain
Thomas H. McLain		   President, Chief
Executive Officer, and
Director 		  June 27, 2003
 
         
 
/s/ Mark Smith
Mark L. Smith		   Senior Vice President,
Finance, Chief Financial Officer,
Chief Accounting Officer, and
Treasurer 		  June 27, 2003
 
         
 
/s/ David J. Gury
David J. Gury		   Chairman of the Board   June 27, 2003
 
         
 
                                       *
David L. Castaldi		   Director    
 
         
 
 
Geoffrey F. Cox, Ph.D.		   Director    
 
         
 
                                       *
George W. Ebright		   Director    

 

Table of Contents

         
Signature   Title   Date
 
                                       *
Richard A. Harvey, Jr.		   Director    
 
         
 
                                       *
Linda Jenckes		   Director    
 
         
 
 
Stephen G. Sudovar		   Director    

*   Signed pursuant to a power of attorney filed with the Securities and Exchange Commission on June 8, 2000.
         
/s/ David J. Gury
David J. Gury		   Attorney-in-fact   June 27, 2003

     The Plan. Pursuant to the requirements of the Securities Act, the Plan administrator has duly caused this Amendment to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Boca Raton, State of Florida, on this 27th day of June, 2003.

         
    NABI-ROCKVILLE SAVINGS & RETIREMENT PLAN
         
    By:   Nabi Biopharmaceuticals, Plan Administrator
         
    By:   /s/ Mark Smith
       
        Mark L. Smith
Senior Vice President, Finance, Chief
Financial Officer, Chief Accounting
Officer, and Treasurer

  -----END PRIVACY-ENHANCED MESSAGE-----